Table of Contents
ISRN Pharmaceutics
Volume 2012, Article ID 730624, 10 pages
http://dx.doi.org/10.5402/2012/730624
Research Article

Use of Response Surface Methodology in the Formulation and Optimization of Bisoprolol Fumarate Matrix Tablets for Sustained Drug Release

1Department of Pharmaceutics, Bengal College of Pharmaceutical Sciences and Research, Durgapur, West Bengal 713212, India
2Department of Pharmaceutics, Seemanta Institute of Pharmaceutical Sciences, Mayurbhanj, Odisha 757086, India

Received 20 October 2012; Accepted 6 November 2012

Academic Editors: S. Raic-Malic and C. Safak

Copyright © 2012 Jadupati Malakar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Üner and B. Çelebi, “Design of hydralazine hydrochloride matrix tablets based on various polymers and lipids,” Indian Journal of Pharmaceutical Education and Research, vol. 46, no. 1, pp. 75–87, 2012. View at Google Scholar
  2. A. Moin and H. G. Shivakumar, “Formulation of sustained-release diltiazem matrix tablets using hydrophilic gum blends,” Tropical Journal of Pharmaceutical Research, vol. 9, no. 3, pp. 283–291, 2010. View at Google Scholar · View at Scopus
  3. U. Mandal, V. Gowda, A. Ghosh, S. Selvan, S. Solomon, and T. K. Pal, “Formulation and optimization of sustained release matrix tablet of metformin HCl 500 mg using response surface methodology,” Yakugaku Zasshi, vol. 127, no. 8, pp. 1281–1290, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. Ü. Gönüllü, M. Üner, G. Yener, and T. Altinkurt, “Introduction of sustained release opipramol dihydrochloride matrix tablets as a new approach in the treatment of depressive disorders,” International Journal of Biomedical Sciences, vol. 2, pp. 337–343, 2006. View at Google Scholar
  5. S. I. Abdel-Rahman, G. M. Mahrous, and M. El-Badry, “Preparation and comparative evaluation of sustained release metoclopramide hydrochloride matrix tablets,” Saudi Pharmaceutical Journal, vol. 17, no. 4, pp. 283–288, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. N. C. Joshi, Z. Ahmad, S. K. Mishra, and R. Singh, “Formulation and evaluation of matrix tablet of Tramadol hydrochloride,” Indian Journal of Pharmaceutical Education and Research, vol. 45, no. 4, pp. 360–363, 2011. View at Google Scholar
  7. M. C. Gohel, R. K. Parikh, S. A. Nagori, and D. G. Jena, “Fabrication of modified release tablet formulation of metoprolol succinate using hydroxypropyl methylcellulose and xanthan gum,” AAPS PharmSciTech, vol. 10, no. 1, pp. 62–68, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. N. A. Peppas and A. R. Khare, “Preparation, structure and diffusional behavior of hydrogels in controlled release,” Advanced Drug Delivery Reviews, vol. 11, no. 1-2, pp. 1–35, 1993. View at Google Scholar · View at Scopus
  9. I. Singh, P. Kumar, S. Kumar, and V. Rana, “Formulation and development of matrix tablets of tramadol using katira gum as release modifier,” Journal of the Pharmaceutical Society of Japan, vol. 130, no. 9, pp. 1225–1231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. H. J. Schliep and J. Harting, “β1-selectivity of bisoprolol, a new β-adrenoceptor antagonist, in anesthetized dogs and guinea pigs,” Journal of Cardiovascular Pharmacology, vol. 6, no. 6, pp. 1156–1160, 1984. View at Google Scholar · View at Scopus
  11. Y. T. Dangat, N. A. Bari, S. C. Jagdale, A. R. Chabukswar, and B. S. Kuchekar, “Controlled release from bisoprolol fumarate buccal patches,” Der Pharmacia Sinca, vol. 3, pp. 317–320, 2012. View at Google Scholar
  12. A. K. Nayak and D. Pal, “Development of pH-sensitive tamarind seed polysaccharide-alginate composite beads for controlled diclofenac sodium delivery using response surface methodology,” International Journal of Biological Macromolecules, vol. 49, pp. 784–793, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. H. N. Shivakumar, P. B. Patel, B. G. Desai, P. Ashok, and S. Arulmozhi, “Design and statistical optimization of glipizide loaded lipospheres using response surface methodology,” Acta Pharmaceutica, vol. 57, no. 3, pp. 269–285, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. C. G. Varelas, D. G. Dixon, and C. A. Steiner, “Zero-order release from biphasic polymer hydrogels,” Journal of Controlled Release, vol. 34, no. 3, pp. 185–192, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. N. V. Mulye and S. J. Turco, “An examination of assumptions underlying the first-order kinetic model for release of water-soluble drugs from dicalcium phosphate dihydrate matrices,” Drug Development and Industrial Pharmacy, vol. 22, no. 7, pp. 673–679, 1996. View at Google Scholar · View at Scopus
  16. T. Higuchi, “Rate of release of medicaments from ointment bases containing drugs in suspension,” Journal of Pharmaceutical Sciences, vol. 50, pp. 874–875, 1961. View at Google Scholar · View at Scopus
  17. R. W. Korsmeyer, R. Gurny, and E. Doelker, “Mechanisms of solute release from porous hydrophilic polymers,” International Journal of Pharmaceutics, vol. 15, no. 1, pp. 25–35, 1983. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Malakar, A. K. Nayak, and D. Pal, “Development of cloxacillin loaded multiple-unit alginate-based floating system by emulsion-gelation method,” International Journal of Biological Macromolecules, vol. 50, no. 1, pp. 138–147, 2012. View at Publisher · View at Google Scholar
  19. A. Nayak, B. Laha, and K. Sen, “Development of hydroxyapatite-ciprofloxacin bone-implants using quality by design,” Acta Pharmaceutica, vol. 61, no. 1, pp. 25–36, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Shah and K. Pathak, “Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 23 full-factorial design,” AAPS PharmSciTech, vol. 11, no. 2, pp. 489–496, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. US Pharmacopoeia National Formulary, USP 23/NF 18, United States Pharmacopoeia Convention Inc., Rockville, Md, USA, 2000.
  22. L. V. Allen, N. G. Popovich, and H. C. Ansel, Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 8th edition, 2004.